Protocol for generating an in vitro 3D multicellular culture model of ovarian high-grade serous carcinoma
Open Access
- 23 February 2026
- journal article
- Published by Elsevier in STAR Protocols
- Vol. 7 (1) , 104397
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk Fonden (NNF21OC0070381)
- Innovationsfonden (/ERA PerMed JTC2020)
- Innovationsfonden (0204-00005B)
- H2020 Marie Skłodowska-Curie Actions (101063359)
- Kræftens Bekæmpelse (R374-A22457)
- Horizon 2020 Framework Programme
This publication has 6 references indexed in Scilit:
- A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoidsDevelopmental Cell, 2023
- Ovarian cancer mutational processes drive site-specific immune evasionNature, 2022
- Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancerNature Communications, 2022
- Optimized Transgene Delivery Using Third‐Generation LentivirusesCurrent Protocols in Molecular Biology, 2020
- Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancerEMBO Molecular Medicine, 2020
- Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human CancersCancer Discovery, 2018